Daniel Reker
Papers
2
Total Citations
70
H-Index
2
About
Daniel Reker is a pioneering researcher at the intersection of artificial intelligence, drug delivery, and pharmaceutical engineering. His work centers on developing computational and robotic platforms to accelerate the design and screening of advanced drug formulations. Reker’s major contributions include the creation of “TuNa-AI,” a hybrid kernel machine that simultaneously optimizes both material selection and component ratios for tunable nanoparticles—a breakthrough that addresses a critical gap in AI-driven drug delivery. With 52 citations, his 2020 study on a robotically handled whole-tissue culture system for screening oral drug formulations demonstrates his commitment to bridging automation and biological relevance. This work has set a new standard for high-throughput, physiologically meaningful drug testing. Reker’s research is notable for its interdisciplinary approach, merging machine learning, robotics, and materials science to solve real-world pharmaceutical challenges. His growing citation impact reflects the field’s recognition of his innovative methods, which promise to streamline the development of safer, more effective nanomedicines. For students and researchers, Reker exemplifies how AI and automation can revolutionize drug formulation design.
Research Focus
Key Achievements
Top Papers
- 1
- 2